Get notified of page updates
Education > XRAY > Search Results

FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program

How To Use XRAY
Search by Topic Submit an Article for Review

All XRAYs

141 through 150 of 311

Relevance: Medium-High

Strength of Science: Medium-Low

Study : Do hair dyes or straighteners increase breast cancer risk?

Relevance: Medium-High

Strength of Science: Medium-Low

Most relevant for: Young women who use hair dye or straighteners

Many women use products to color or straighten their hair. A large U.S. study linked the use of permanent hair dye and straighteners to increased breast cancer risk, particularly among black women. This XRAY reviews the limitations of this study and highlights the need for additional research before accepting these conclusions. (1/29/20)

Read More

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

Study : Second surgery may not benefit women with recurrent ovarian cancer

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

Most relevant for: Women with recurrent ovarian cancer

Many women who have recurrent ovarian cancer have a second surgery. A new study suggests that women with platinum sensitive cancers who get chemotherapy alone may do as well as or better than women who have surgery followed by chemotherapy. (1/21/20)

Read More

Relevance: High

Strength of Science: Medium

View Related Clinical Trials

Study : How does a breast cancer diagnosis affect employment of young women?

Relevance: High

Strength of Science: Medium

View Related Clinical Trials

Most relevant for: Young women with breast cancer

Most young women who are diagnosed with breast cancer remain employed one year after their diagnosis. Among breast cancer patients who were unemployed a year later, half reported that their unemployment was due to health issues. The issues that were most associated with unemployment were stage of cancer and financial stress prior to diagnosis. (1/10/20)

Read More

Relevance: Medium-High

Strength of Science: High

Research Timeline: Human Research

View Related Clinical Trials

Study : A new breast cancer drug improves overall survival among people with brain and other metastases

Relevance: Medium-High

Strength of Science: High

Research Timeline: Human Research

View Related Clinical Trials

Most relevant for: People with metastatic breast cancer

A promising new drug called tucatinib combined with standard therapy shows benefit for women with HER2-positive metastatic breast cancer. Women who took tucatinib experienced longer progression-free survival (time before their cancer worsened), longer overall survival time and response of cancer (shrinking or disappearing). Strikingly, better outcomes were also seen for women with brain metastases, which is often difficult to treat. (12/20/19) 

THIS INFORMATION HAS BEEN UPDATED on 04/17/20:  The U.S. Food and Drug Administration has approved Tukysa (tucatinib) for use in combination with trastuzumab (Herceptin) and capecitabine for patients with advanced or metastatic HER2-positive breast cancer, including patients with brain metastases (disease that has spread to the brain). Patients who have received one or more treatments targeting Her2 in the metastic setting are eligible to receive Tukysa. Tukysa  is an oral (tablet) tyrosine kinase inhibitor which is taken twice daily. 

 

 

Read More

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Study : Women who exercise have lower breast cancer risk whether or not they have a family history of breast cancer

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: Young, high risk women

The effect of physical activity on breast cancer risk was looked at  in a study of over 15,000 women. The results suggest that exercise lowers breast cancer risk regardless of family  history of breast cancer or menopausal status.  (12/6/19)

Este artículo está disponible en español.

Read More

Relevance: High

Research Timeline: Post Approval

View Related Clinical Trials

Update : Genetic causes of hereditary pancreatic cancer: BRCA and beyond

Relevance: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: People diagnosed with pancreatic cancer

An update on hereditary pancreatic cancer presented at the annual American Society of Clinical Oncology meeting covered genes and lifetime risk. The update emphasized that all pancreatic cancer patients should be offered genetic counseling and testing. Genetic test results may impact treatment, screening for other cancers and risk to family members. (11/26/19)

Read More

Relevance: Medium-High

Strength of Science: Medium-High

Research Timeline: Human Research

View Related Clinical Trials

Study : A new blood test may help predict early-stage breast cancer patients at highest risk for recurrence

Relevance: Medium-High

Strength of Science: Medium-High

Research Timeline: Human Research

View Related Clinical Trials

Most relevant for: People with early-stage breast cancer

Which patients are at risk for a relapse of early-stage breast cancer? Tests to predict recurrence would help find people who need more monitoring after treatment and provide a chance to find and treat them earlier. This study looked at whether a blood test for tumor DNA (called circulating tumor DNA or ctDNA) is useful for finding people with recurrence earlier than current clinical practice. (11/4/19)

Este artículo está disponible en español.

Read More

Relevance: High

Strength of Science: High

Research Timeline: Human Research

View Related Clinical Trials

Study : Niraparib increases progression-free survival in patients with newly diagnosed ovarian cancer

Relevance: High

Strength of Science: High

Research Timeline: Human Research

View Related Clinical Trials

Most relevant for: Women newly-diagnosed with ovarian cancer

This study looked at the effectiveness and safety of niraparib (Zejula), a PARP inhibitor, as maintenance therapy in newly diagnosed ovarian cancer patients who had a response to chemotherapy. (11/5/19)

Read More

Relevance: Medium-Low

Research Timeline: Human Research

Personal Story : A “flu shot” against breast cancer? Not so fast

Relevance: Medium-Low

Research Timeline: Human Research

Most relevant for: Women diagnosed with Ductal Carcinoma In Situ (DCIS)

There have been multiple reports in the media of a Florida woman who had a "shot" to treat her DCIS with a promising outcome. This XRAY reviews the underlying story about this early breast cancer vaccine trial. (10/25/19)

Read More

Relevance: High

Quality of Writing: High

View Related Clinical Trials

Personal Story : Running marathons with metastatic breast cancer? Yes!

Relevance: High

Quality of Writing: High

View Related Clinical Trials

Most relevant for: Women with metastatic breast cancer

Runner’s World Magazine featured Sarah Smith, a metastatic breast cancer patient who runs marathons and ultra-marathons. By telling her story, Sarah wants to encourage people to stay active, despite the challenges that life may bring. (10/13/19)

Read More